, Tracking Stock Market Picks
Enter Symbol:
Rating: MNKD

Mannkind Corporation (NASDAQ: MNKD) downgraded to Underperform by BofA/Merrill

Friday,  Sep 6, 2013  8:25 AM ET by Dave Ficere

BofA/Merrill downgraded Mannkind Corporation (NASDAQ: MNKD) to Underperform.
Previously BofA/Merrill rated Neutral Mannkind Corporation (NASDAQ: MNKD) on 06/07/2013, when the stock price was $7.44.

Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company's lead product, the Technosphere Insulin System, consists of the Company's dry-powder Technosphere formulation of insulin and the Company's MedTone inhaler through which the powder is inhaled into the deep lung.


RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy